Vetamol

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Vetamol

What is Vetamol? Definition and Classification

Property Description
Active ingredient Norfloxacin
Form Oral Tablets, Ophthalmic Solution
Pharmacological class Fluoroquinolone antibiotic
General purpose Clearing bacterial infections
Origin Synthetic

1. Vetamol: Definition and Classification as a Fluoroquinolone

Vetamol is a synthetic antibacterial agent prescribed to target and eliminate susceptible bacteria within the body. Its core therapeutic identity stems from the single active compound, Norfloxacin, which places it specifically within the Fluoroquinolone antibiotic pharmacological class. This classification signifies a modern group of antimicrobials developed through chemical synthesis, distinguishing them from older, naturally derived antibiotics. Norfloxacin serves as an effective agent against key bacterial pathogens.


2. Composition, Origin, and Available Forms

The composition of Vetamol is based on the single, synthetic active compound, Norfloxacin. The medicine is manufactured in two distinct dosage form(s) for different route(s) of administration: oral tablets, intended for systemic use throughout the body, and an ophthalmic solution for local, ocular use. Norfloxacin's action is rooted in its mechanism against bacterial DNA synthesis, which targets and kills the pathogen. The availability of both forms, systemic and local, is a differentiating factor that broadens the applicability of the Norfloxacin formulation.


3. General Purpose of the Norfloxacin Antimicrobial Agent

The general therapeutic purpose of Vetamol is to address and resolve medical conditions caused by bacterial infections by exerting a decisive bactericidal action against the pathogen. Norfloxacin achieves this by disrupting the bacteria's vital processes, specifically inhibiting enzymes essential for the synthesis and repair of the bacterial cell's genetic material. This targeted disruption is an effective strategy for pathogen eradication in a therapeutic context. This mechanism prevents the bacteria from multiplying and serves the fundamental purpose of infection clearance.

What side effects are possible with Vetamol?

Possible Side Effects and Safety Information

The safety profile for Vetamol, which contains acetaminophen (paracetamol), primarily addresses the risks of acute toxicity and rare, serious skin reactions. This information is derived from comprehensive reviews by governmental health and chemical safety authorities.

Serious and Clinically Significant Risks

Category Description and Regulatory Classification
Severe Skin Reactions Acetaminophen is associated with the rare risk of serious and potentially fatal dermatological reactions, including Stevens-Johnson Syndrome (SJS), Toxic Epidermal Necrolysis (TEN), and Acute Generalized Exanthematous Pustulosis (AGEP). Symptoms can include skin reddening, rash, and blistering, and may occur even with first-time use. Regulatory labeling mandates an "Allergy alert" to stop use and seek immediate medical help if any skin reaction occurs.
Acute Toxicity The active ingredient is classified as acutely toxic (Category 4) if swallowed, requiring precautionary hazard statements like “Harmful if swallowed.” This classification under chemical safety standards emphasizes the risk of overdose, which can lead to severe liver injury, kidney damage, and, in severe cases, death.

Population and Context-Specific Safety

Specific caution is advised for patients with pre-existing liver disease, and the medication is generally contraindicated in those with severe or active liver impairment due to the potential for hepatotoxicity. Non-prescription products typically carry warnings against concurrent use with other medications containing the same active ingredient to prevent accidental overdose.

Common Adverse Reactions

While serious reactions are rare, documented general side effects (not specified by frequency) may include gastrointestinal disturbances such as nausea, vomiting, constipation, anxiety, and difficulty sleeping (insomnia). These effects often resolve as the body adjusts to the medicine.

This structure summarizes the key risks and mandatory warnings from regulatory documents; it does not constitute clinical advice or recommendations.

Overdose and Emergency Response

Overdose and When to Seek Help

This information is derived strictly from official government regulatory documents concerning overdosage risk and management.

Overdose from Vetamol, defined as administration in doses higher than officially recommended, is a medical emergency due to the risk of severe and delayed hepatotoxicity (liver damage). The hazard of overdose is greater in individuals with chronic alcoholism or pre-existing liver conditions.

Documented Overdose Manifestations

Initial symptoms, which may appear within the first 24 hours, include:

  • Nausea and vomiting
  • Pallor and anorexia
  • Abdominal pain

Signs of delayed, serious toxicity (12 to 48 hours post-ingestion) involve specific laboratory abnormalities such as increased liver enzymes (AST, ALT) and prothrombin time. Unmanaged toxicity can progress to hepatocellular insufficiency, metabolic acidosis, encephalopathy, and death.

Required Emergency Actions

Immediate medical advice must be sought in the event of an overdose, even if the patient feels well. The risk of severe, irreversible liver damage is delayed, making early intervention critical.

Specific emergency measures include:

  1. Antidote Administration: The antidote, N-acetylcysteine, should be administered as soon as possible according to established medical guidelines.
  2. Decontamination: Administration of activated charcoal may be considered if the toxic dose was taken within one hour of seeking help.

Management is primarily supportive, treating symptoms while maintaining vital functions. Monitoring of laboratory values (e.g., liver function tests) is required to track the progression of toxicity.

Therapeutic Uses of Vetamol

What Vetamol Treats: Main Uses and Benefits

Vetamol's active ingredient is paracetamol (also known as acetaminophen). It is considered relevant for the supportive management of symptoms related to physical discomfort and systemic imbalance. Its therapeutic domains are applicable across domains where additional symptomatic support is needed.

Paracetamol is a mild analgesic and antipyretic agent, commonly used for managing symptoms that interfere with daily comfort. It is applied in addressing painful and febrile conditions such as headache (including migraine), toothache, sore throat, backache, muscular aches, and menstrual cramps (dysmenorrhoea).


The medicine assists with maintaining functional stability by easing the overall symptom burden. It is commonly used in scenarios where additional management of discomfort is required and during phases when symptoms become more noticeable. It may support the patient during difficult episodes by easing distress.

Vetamol can be part of symptomatic management for conditions associated with acute or disruptive episodes. It contributes to improved comfort during symptomatic periods, helping patients cope more steadily with symptom fluctuations.


Quick Fact: Relevant for Symptoms that Create Noticeable Physiological Strain

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Vetamol — official regulatory information

The following rules define the eligibility for Vetamol, based on the official prescribing information for its active ingredient, Norfloxacin (a fluoroquinolone antibiotic).


Eligibility scope

Classification Rule Summary (Based on Regulatory Labeling)
Populations Contraindicated Must not be used in patients with known hypersensitivity to norfloxacin or any other fluoroquinolone, or a history of tendinitis/tendon rupture linked to this class of antibiotics. Also contraindicated in patients with myasthenia gravis.
Age-Related Rules Use not established and not recommended in children and growing adolescents (typically under 18 years) due to safety concerns regarding developing joints. Use is established for adults.
Pregnancy and Lactation Generally contraindicated or restricted; use during pregnancy and breastfeeding is only permissible when the potential benefit to the mother is officially judged to outweigh the potential risk to the fetus or infant.
Conditional Use Patients with reduced renal function (kidney impairment) are eligible only under the condition that a dosage alteration is implemented. Caution is required in patients with certain CNS disorders (e.g., epilepsy) or risk factors for QTc prolongation.

Connection to the overall eligibility profile

Regulatory documents establish an eligibility profile primarily for the adult population, with absolute prohibitions against use in patients with specific prior adverse reactions or certain neuromuscular conditions. Eligibility for use in patients with impaired organ function is conditional, explicitly requiring official dosage adjustments or special caution as stated in the prescribing information.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documentation identifies several categories of medicines that pose a risk of interaction with Vetamol (methylphenidate), leading to specific constraints on their combined use.

Interacting Product Category Regulatory Constraint/Requirement
Monoamine Oxidase Inhibitors (MAOIs) Contraindicated for concurrent use and within 14 days of MAOI discontinuation due to risk of hypertensive crisis.
Vasopressor Agents Use with caution; requires close monitoring of blood pressure. Vetamol may potentiate the pressor effects.
Halogenated Anesthetics Avoid use on the day of surgery due to the risk of a sudden, significant increase in blood pressure and heart rate.

Co-administration with Coumarin Anticoagulants (e.g., warfarin), Anticonvulsants (e.g., phenobarbital, phenytoin, primidone), and certain Antidepressants (e.g., tricyclics, selective serotonin reuptake inhibitors [SSRIs]) requires particular attention. Regulatory documents indicate that Vetamol may inhibit the metabolism of these medications, potentially increasing their plasma concentrations and risk of adverse effects, such as bleeding in the case of anticoagulants. When used together, close clinical and laboratory monitoring is necessary, which may lead to an adjustment of the dose for the interacting drug. Additionally, the use of alcohol is officially advised against, as it may exacerbate central nervous system adverse effects.

Mechanism of Action

Vetamol exerts its pharmacodynamic effects primarily through enzyme modulation within the central nervous system (CNS) and spinal cord. This activity results in the modification of specific signaling cascades that regulate heightened physiological responses.

Central Prostaglandin Synthesis Modulation

This domain involves the inhibition of cyclooxygenase (COX) enzymes, particularly in environments with low peroxide concentrations. Reduction of COX activity decreases the biosynthesis of specific prostaglandins (PGs) and related factors. This action directly modulates the hypothalamic thermoregulatory center, initiating signaling sequences that influence systemic physiological outcomes.

Endocannabinoid and TRPV1 Receptor Engagement

The drug's activity includes its metabolism into the bioactive compound, AM404, predominantly within the CNS. This metabolite activates transient receptor potential vanilloid 1 (TRPV1) receptors and may involve interaction with cannabinoid (CB1) receptors. This pathway supports the inhibition of nociceptive signal transmission in central pathways by influencing descending inhibitory serotonergic signaling.

Dosage and Administration Information

How Vetamol is Used: Official Administration and Dosing

Vetamol, which contains the active ingredient Paracetamol (Acetaminophen), is used according to established prescribing instructions. These instructions govern the route of intake, standardized dose, frequency, and overall duration of use.

Official Administration Protocol

The medicine is officially administered via the oral route, with typical formulations including oral tablets, capsules, and solutions. The medicine may be taken with or without food, though administration without food may accelerate the onset of action.

Standard Dosing Regimen

The established adult dosing parameters define both the single intake amount and the maximum allowable amount over a 24-hour period. Doses must be separated by a specific time interval.

Dosing Parameter Official Instruction (Adults)
Single Dose Range 500 mg to 1,000 mg
Dose Frequency Repeat every 4 to 6 hours as required
Maximum Daily Dose Must not exceed 4,000 mg (4 grams) in 24 hours

Usage Constraints and Adjustments

Established instructions include constraints on the duration of use for self-medication, which is generally limited. If pain or fever persists beyond 3 to 5 days (pain) or 3 days (fever), use should be discontinued. Dose adjustments are established for certain populations; for instance, in cases of severe renal impairment (GFR < 10 ml/min), the dose is reduced to 500 mg with an extended 8-hour interval. It is critical that the maximum recommended daily dose is not exceeded from all sources combined.

Recent Clinical Evidence

Research evidence / Overview of Studies for Vetamol

1. Evidence for Use in Acute Mild to Moderate Pain

Research involving Vetamol for short-term physical discomfort is largely supported by Randomized Controlled Trials (RCTs) and comprehensive Systematic Reviews that synthesize data from many individual studies. These trials typically included adults and adolescents experiencing acute, temporary conditions characterized by outcomes related to physical discomfort, such as headache, certain musculoskeletal aches, or menstrual cramps.

Studies explored how symptoms change over time by measuring pain intensity scores and observing the time elapsed until initial symptom change was reported. Findings describe patterns observed in the studies where outcomes related to pain intensity change were measured during short observation windows, typically within the first few hours following administration.

2. Evidence for Use in Fever Reduction (Antipyretic Effect)

Research involving Vetamol has examined systemic or functional imbalance, specifically fever, and is supported by a large volume of clinical data. Research in this area used short-term RCTs, heavily involving Children as the primary population, alongside adults with fever associated with various medical states.

The main outcomes studied monitored physiological strain or stress by evaluating changes in body temperature from baseline and the duration for which such a change was maintained. Studies report how symptoms evolved in the observed populations, indicating patterns related to temperature change measured during the study period.

3. Research Landscape for Chronic Pain Conditions

The evidence base for Vetamol in long-lasting conditions, such as osteoarthritis and chronic low back pain, is built on intermediate-term RCTs and large-scale Observational Studies. Studies explored conditions characterized by functional limitations and periods of heightened symptoms. Findings were mixed across studies for these chronic conditions. Systematic reviews and RCTs reported that the measured changes in pain and function did not reliably differ when compared against placebo controls over periods of 6 to 12 weeks. For osteoarthritis, some studies reported small observations related to changes in pain scores.

4. Evidence in Special Populations

Vetamol was evaluated in specific groups where symptoms may vary in intensity or physiological response, including Children and Older Adults. Observational studies have also examined use during pregnancy. While regulatory and scientific bodies have documented the use of Vetamol for fever and pain management when necessary, some observational studies have described associations between longer duration or higher levels of use and small changes in neurodevelopmental outcomes in offspring. However, some advanced analyses, such as sibling-controlled studies, have suggested that these small associations may be explained by shared familial factors rather than the specific exposure studied. Evidence highlights what is known—and what is still uncertain—regarding non-causal associations.

5. What is Still Uncertain About Vetamol: Evidence Gaps

Research provides insight into short-term changes, but several limitations and gaps remain. There is limited information for long-term outcomes from controlled trials, meaning the characteristics of continuous use over many months are not fully established. Evidence quality varies across studies for chronic pain, and data for certain groups remain insufficient, especially regarding long-term functional outcomes in chronic conditions.

Key Studies & References Treating fever in children: paracetamol or ibuprofen? (NCBI Bookshelf)

Frequently Asked Questions (FAQ)

Common questions about Vetamol (FAQ)

Q: How quickly should I expect Vetamol to start working?

A: Official studies indicate that the peak concentration of the active ingredient in the bloodstream is generally reached about one hour after the dose is taken. This measurement shows when the medicine is most available in the body. The time it may take to notice any change in symptoms can vary among individuals.

Q: What happens if I miss taking Vetamol?

A: Regulatory patient information often advises that if a dose is missed, it should generally be skipped, and the next dose should be taken at the regularly scheduled time. Official guidance typically notes that a double dose should not be taken to make up for a missed dose.

Q: Can Vetamol be used long-term?

A: Regulatory bodies have issued communications emphasizing that this class of antibiotics should be used for the shortest duration necessary. This is due to warnings related to disabling and potentially permanent side effects, such as nerve and tendon problems. This restriction reflects official concerns regarding the risk-benefit balance for this drug class.

Q: Are there withdrawal symptoms mentioned when stopping Vetamol?

A: While the term 'withdrawal' is not typically used in regulatory documents, they note that serious adverse effects, such as tendon problems and nerve problems (neuropathy), can occur not only during treatment but also up to several months after stopping the medicine. The occurrence of effects after stopping highlights the need for continued monitoring.

Q: Does Vetamol interact with common over-the-counter pain relievers?

A: Official drug interaction documents focus on prescription medications but do not typically list all common over-the-counter (OTC) pain relievers. The medicine has the potential to interact with certain drugs metabolized by the Cytochrome P450 system in the liver. Patients are generally advised to discuss all medications and products, including OTC items, with their healthcare provider.

Q: Does Vetamol interact with caffeine or alcohol?

A: Official information suggests it may interfere with the way caffeine is processed by the body. Additionally, alcohol use is generally advised against because it may increase central nervous system side effects.

Q: Is the evidence for Vetamol considered strong by regulatory bodies?

A: Regulatory communications have restricted the use of this drug class to infections where no other treatment options are available. Regulatory documents outline the evidence supporting the drug's use in targeted infections, balanced against the identified risks.

Q: Is Vetamol the same as other medicines with similar names?

A: Vetamol is a brand name for the active ingredient norfloxacin. Medicines with similar names may be other brand names containing the same active ingredient, or they may contain similar compounds belonging to the broader fluoroquinolone antibiotic class.

Q: Are there common side effects of Vetamol that people worry about?

A: Official documents list side effects such as nausea, dizziness, and headache. In addition, regulatory warnings highlight that the drug class is associated with potentially serious side effects, specifically tendon issues and nerve problems (peripheral neuropathy).

Q: Does Vetamol cause weight gain or loss?

A: Official regulatory documents list weight changes as an adverse effect that has been reported. However, they do not specify the frequency or direction (gain or loss), suggesting this is not a commonly expected or guaranteed occurrence.

Q: Is it okay to drive after taking Vetamol?

A: Regulatory labeling includes warnings that the medicine may cause effects such as dizziness, confusion, and tremors. Official labeling includes cautions that patients should consider before engaging in activities requiring mental alertness, such as driving or operating machinery.

Q: What should I do if I feel dizzy after taking Vetamol?

A: Dizziness is listed in official documents as a common adverse effect. Official patient information notes that a healthcare professional should be contacted if side effects, including dizziness, are concerning or persistent.

Q: What is the shelf life of Vetamol?

A: The official determination of the medicine's shelf life is indicated by the labeled expiration date found on the packaging. Regulatory requirements state that the medicine must not be used after this expiration date.

Q: Why is Vetamol prescribed for different conditions?

A: The active ingredient, norfloxacin, is indicated for the treatment of specific infections caused by susceptible bacteria. These approved uses commonly include infections of the urinary tract and certain other types of bacterial infections, depending on the bacteria identified.

Q: Are there any specific lifestyle changes mentioned when starting Vetamol?

A: Regulatory patient information advises patients to drink sufficient fluids to help ensure adequate urinary output. Patients are also cautioned in the official documents regarding excessive exposure to the sun due to the reported risk of photosensitivity skin reaction.

Q: Can people who are vegetarian or vegan take Vetamol?

A: The active ingredient itself is synthetic. Official regulatory labeling lists all the inactive ingredients (such as binders and colorants) but does not specify whether the source of every inactive component is animal or non-animal derived.

Q: Is there a generic version of Vetamol available?

A: Yes, the active ingredient, norfloxacin, is an established compound. Regulatory databases list various generic equivalent formulations of the drug that are available.

Q: What kind of studies have been done on Vetamol?

A: Official prescribing information summarizes clinical studies, including randomized, double-blind trials. The research primarily focuses on demonstrating the drug's effectiveness in clearing targeted bacterial infections, such as those in the urinary tract.

Q: Do many people stop taking Vetamol because of side effects?

A: Regulatory documents classify side effects by frequency. Regulatory documentation indicates that immediate discontinuation is required if serious adverse events, such as a severe skin reaction or tendon rupture, are observed.

Q: Is it normal to feel tired in the first few days of taking Vetamol?

A: Official documentation lists both tiredness (malaise) and drowsiness as adverse experiences that have been reported. This suggests that these effects can occur, particularly while the body is adjusting to the medicine.

Q: Is Vetamol a controlled substance?

A: No, regulatory documents indicate that the active ingredient, norfloxacin, is not classified as a controlled substance under the U.S. Controlled Substances Act (CSA) or similar international classifications.

Q: Can Vetamol be taken on an empty stomach?

A: Yes, official regulatory information notes that the absorption of the medicine is generally better when taken on an empty stomach. This typically means taking it at least one hour before or two hours after eating a meal.

Q: How long does Vetamol stay in the system?

A: Official information regarding the drug's processing in the body states that the effective half-life of the active ingredient is typically between three to four hours in healthy volunteers. This is the time it takes for the body to eliminate half of the dose.

Q: What are the main things doctors screen for before prescribing Vetamol?

A: Regulatory warnings require checking for a history of tendon rupture related to this drug class, myasthenia gravis, and certain CNS disorders or risk factors for abnormal heart rhythms (QTc prolongation).

Q: Do official sources list rare side effects of Vetamol?

A: Yes, official regulatory documents list undesirable effects by frequency, including those classified as rare and very rare adverse reactions. These reports include serious events such as severe skin reactions and allergic reactions.

Q: Can Vetamol affect my sleep pattern?

A: Official documents list changes in sleep pattern and difficulty sleeping (insomnia) as reported adverse experiences. This indicates that the medicine has the potential to influence a patient's normal sleep cycle.

Q: Is Vetamol safe for people with kidney problems?

A: For patients with impaired renal function (kidney problems), regulatory documents state that the medicine should be used with caution. Furthermore, a reduced dosage and extended dosing interval is officially necessary for people with significant kidney impairment.

Q: What does the research say about the long-term safety of Vetamol?

A: Regulatory communications note that controlled trials have limited information for long-term outcomes (use over many months). Regulatory communications emphasize the potential for long-lasting and possibly permanent adverse effects on the nervous and musculoskeletal systems.

Q: Is Vetamol commonly known by a different name?

A: Yes, Vetamol is a brand name for the generic drug norfloxacin. It has also been marketed internationally under various other brand names.

Q: How long does the effect of Vetamol last after a single use?

A: Official drug information states that the medicine's effective half-life is approximately three to four hours. Efficacy against bacterial pathogens in the urine is typically maintained for at least 12 hours following a dose.

Q: What is the difference between the main ingredient and the inactive ingredients in Vetamol?

A: Regulatory documents state that the active ingredient is norfloxacin, which is the compound that provides the therapeutic effect (clearing the infection). Inactive ingredients (such as fillers, binders, and colors) are necessary for manufacturing the tablet or solution but have no therapeutic effect.

Q: Does Vetamol require special monitoring during use?

A: Special clinical and laboratory monitoring is noted in regulatory documents when the medicine is used with certain interacting medications, such as anticoagulants and specific antidepressants.

Q: Can Vetamol affect blood sugar levels?

A: Regulatory documents indicate that the medicine's drug class has been associated with changes in blood sugar. These changes can include both low blood sugar (hypoglycemia) and high blood sugar (hyperglycemia), particularly in patients who have diabetes.

Q: Why do some people need a higher strength of Vetamol than others?

A: Regulatory documents define varying dose strengths and treatment durations based on the type and severity of the bacterial infection being treated. Furthermore, the dose may need to be adjusted based on a patient's kidney function.

Q: Does the time of day I take Vetamol matter?

A: Official instructions advise taking the medicine at the same times each day to ensure consistent levels of the drug in the body. For a twice-daily regimen, taking doses approximately 10–12 hours apart is suggested to achieve this consistency.

Q: Is there a maximum length of time Vetamol can be used?

A: The official maximum duration of use is defined by the specific infection being treated. Regulatory regimens can range from single doses for simple infections up to 28 days for certain chronic conditions like prostatitis.

How should Vetamol be stored and disposed of?

Storage and Protection Requirements

Vetamol tablets must be stored at or below 25 C (77 F), or within the controlled room temperature range of 15 C to 30 C (59 F to 86 F), as specified in official labeling. The product must be protected from moisture and excessive heat, meaning high-humidity locations such as bathrooms are prohibited storage environments. It is required to keep the medicine in its original container, which must be kept tightly closed when not in use. The medicine must not be frozen and must not be used after the labeled expiration date. For safety, all medicines must be stored out of the sight and reach of children.

Official Disposal Instructions

Official guidelines state that the preferred method for discarding unused or expired Vetamol is through a local drug take-back program. Disposal via household wastewater (flushing) is prohibited. If a take-back option is unavailable, the medicine may be mixed with an undesirable substance (like coffee grounds), sealed in a container, and placed in the household trash. Disposal of any unused product must be done in accordance with local regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Vetamol found in:

A-Z Index: